Clinical Trial Update: Synvisc to Treat Osteoarthritis of the Temporomandibular Joint [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Synvisc for osteoarthritis of the temporomandibular joint has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED